JPH06247842A - リポソーム組成物の製造方法 - Google Patents

リポソーム組成物の製造方法

Info

Publication number
JPH06247842A
JPH06247842A JP5056378A JP5637893A JPH06247842A JP H06247842 A JPH06247842 A JP H06247842A JP 5056378 A JP5056378 A JP 5056378A JP 5637893 A JP5637893 A JP 5637893A JP H06247842 A JPH06247842 A JP H06247842A
Authority
JP
Japan
Prior art keywords
drug
liposome composition
lipid
added
organic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5056378A
Other languages
English (en)
Japanese (ja)
Inventor
Koji Munechika
公司 棟近
Tomoyo Seki
智予 関
Tokuhide Kishi
徳秀 貴志
Hiroshi Matsuda
寛 松田
Yasuo Ueda
泰生 上田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Priority to JP5056378A priority Critical patent/JPH06247842A/ja
Priority to CA002155958A priority patent/CA2155958A1/en
Priority to EP94904745A priority patent/EP0688563A4/en
Priority to US08/505,180 priority patent/US5662931A/en
Priority to PCT/JP1994/000075 priority patent/WO1994018948A1/ja
Priority to KR1019950703318A priority patent/KR960700690A/ko
Priority to TW083103032A priority patent/TW247274B/zh
Publication of JPH06247842A publication Critical patent/JPH06247842A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP5056378A 1993-02-23 1993-02-23 リポソーム組成物の製造方法 Pending JPH06247842A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP5056378A JPH06247842A (ja) 1993-02-23 1993-02-23 リポソーム組成物の製造方法
CA002155958A CA2155958A1 (en) 1993-02-23 1994-01-20 Process for preparing liposome composition
EP94904745A EP0688563A4 (en) 1993-02-23 1994-01-20 METHOD FOR PRODUCING A LIPOSOME PREPARATION
US08/505,180 US5662931A (en) 1993-02-23 1994-01-20 Process for preparing liposome composition
PCT/JP1994/000075 WO1994018948A1 (fr) 1993-02-23 1994-01-20 Procede de production d'une composition de liposome
KR1019950703318A KR960700690A (ko) 1993-02-23 1994-01-20 리포좀 조성물의 제조방법(Process for producing liposome composition)
TW083103032A TW247274B (OSRAM) 1993-02-23 1994-04-07

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5056378A JPH06247842A (ja) 1993-02-23 1993-02-23 リポソーム組成物の製造方法

Publications (1)

Publication Number Publication Date
JPH06247842A true JPH06247842A (ja) 1994-09-06

Family

ID=13025604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5056378A Pending JPH06247842A (ja) 1993-02-23 1993-02-23 リポソーム組成物の製造方法

Country Status (7)

Country Link
US (1) US5662931A (OSRAM)
EP (1) EP0688563A4 (OSRAM)
JP (1) JPH06247842A (OSRAM)
KR (1) KR960700690A (OSRAM)
CA (1) CA2155958A1 (OSRAM)
TW (1) TW247274B (OSRAM)
WO (1) WO1994018948A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012105485A1 (ja) 2011-01-31 2012-08-09 マルホ株式会社 高分子逆ミセルを含む皮膚用組成物およびその製造方法

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222752T1 (de) * 1993-10-06 2002-09-15 Amgen Inc Stabile protein-phospholipid zusammensetzungen und verfahren
US5874075A (en) * 1993-10-06 1999-02-23 Amgen Inc. Stable protein: phospholipid compositions and methods
CN1055640C (zh) * 1996-11-29 2000-08-23 沃维汉 人降钙素基因相关肽脂质体组合物及其制法
PT1014946E (pt) 1997-09-18 2010-07-06 Pacira Pharmaceuticals Inc COMPOSIÎES ANESTéSICAS LIPOSSOMAIS DE LIBERTAÆO SUSTENTADA
ATE554748T1 (de) 1997-11-14 2012-05-15 Pacira Pharmaceuticals Inc Herstellung von multivesikulären liposomen
FR2771636B1 (fr) * 1997-12-01 2001-06-15 Capsulis Procede perfectionne pour eviter la degradation d'un principe actif
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
NZ509186A (en) 1998-07-17 2005-01-28 Skyepharma Inc Biodegradable compositions for the controlled release of encapsulated substances
EP1365794A2 (en) * 2000-07-21 2003-12-03 Lue, Tom Prevention and treatment of sexual arousal disorders
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
WO2002087543A1 (en) * 2001-05-01 2002-11-07 Biozone Laboratories, Inc. Sustained release formulations for nifedipine, dextromethorphan, and danazol
JP3742602B2 (ja) * 2001-05-09 2006-02-08 株式会社カネカ 還元型補酵素ｑの安定な溶液
JP2004532252A (ja) * 2001-05-31 2004-10-21 スカイファーマ インコーポレーテッド リポソームおよびミクロスフェア中のナノ懸濁物のカプセル化
BRPI0105509B8 (pt) * 2001-11-05 2021-05-25 Univ Minas Gerais formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
NZ563328A (en) 2002-10-16 2009-08-28 Euro Celtique Sa Antibodies that bind cell-associated CA 125/0772P and methods of use thereof
US7179484B2 (en) * 2002-11-06 2007-02-20 Azaya Therapeutics, Inc. Protein-stabilized liposomal formulations of pharmaceutical agents
US20050032113A1 (en) * 2003-07-17 2005-02-10 Mitsubishi Pharma Corporation Membrane protein library for proteome analysis and method for preparing same
TWI262798B (en) * 2003-12-31 2006-10-01 Ind Tech Res Inst Liposome and drug deliver system
US7032632B2 (en) * 2004-09-27 2006-04-25 Owens-Illinois Prescription Products Inc. Measuring and dispensing closure
CA2523032A1 (en) * 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccines for cancer therapy
US20090017108A1 (en) * 2007-07-11 2009-01-15 Alexander Yuzhakov Liposome compositions for treatment of hepatitis C
WO2009039628A1 (en) 2007-09-27 2009-04-02 Immunovaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
US20110070298A1 (en) 2008-06-05 2011-03-24 Immunovaccine Technologies Inc. Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
US8987241B2 (en) 2009-06-19 2015-03-24 Altos Vision Limited Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
WO2012021107A2 (en) * 2010-08-12 2012-02-16 Nanyang Technological University A liposomal formulation for ocular drug delivery
CN113876945A (zh) 2011-10-06 2022-01-04 免疫疫苗技术有限公司 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR77320B (OSRAM) * 1980-12-22 1984-09-11 Procter & Gamble
US5141674A (en) * 1984-03-08 1992-08-25 Phares Pharmaceutical Research N.V. Methods of preparing pro-liposome dispersions and aerosols
FR2561101B1 (fr) * 1984-03-13 1986-10-31 Paris Sud Universite Procede de preparation de liposomes et liposomes ainsi obtenus
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
JPH03275632A (ja) * 1990-03-23 1991-12-06 Nippon Oil & Fats Co Ltd リポソーム製剤
EP0451791A2 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012105485A1 (ja) 2011-01-31 2012-08-09 マルホ株式会社 高分子逆ミセルを含む皮膚用組成物およびその製造方法

Also Published As

Publication number Publication date
CA2155958A1 (en) 1994-09-01
TW247274B (OSRAM) 1995-05-11
EP0688563A1 (en) 1995-12-27
WO1994018948A1 (fr) 1994-09-01
US5662931A (en) 1997-09-02
EP0688563A4 (en) 1998-02-04
KR960700690A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
JPH06247842A (ja) リポソーム組成物の製造方法
CA2259179C (en) Emulsion formulations for hydrophilic active agents
RU2632433C2 (ru) Липидный преконцентрат с замедленным высвобождением фармакологически активного вещества и фармацевтическая композиция, содержащая его
JP3577312B2 (ja) 定義された脂質系を含有する薬剤組成物
JP4613294B2 (ja) エリスロポイエチンのリポソーム分散物
JPH0240644B2 (OSRAM)
EP0161445A1 (en) Water soluble drug complex and method for production of same
JPS60155109A (ja) リポソ−ム製剤
JPH0834745A (ja) アルファトコフェロールをベースにした小胞体
JPH0559087B2 (OSRAM)
JPH09501169A (ja) 小胞に生体高分子物質を高度に充填する方法
JP3202999B2 (ja) 肝移行性リポソーム製剤
EP0726761B1 (en) Microparticular pharmaceutical compositions in micellar form
JP2688235B2 (ja) 医薬物質含有脂肪乳剤の用時調製型キットおよび医薬物質含有脂肪乳剤の調製方法
JP2002510311A (ja) トコフェロールにより安定化された吸引用プロリポソーム粉末
Bergers et al. Interleukin-2-containing liposomes: interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccines
JPWO2006121199A1 (ja) 脂質小胞体組成物
JPH10502328A (ja) 蛋白質をその中にカプセル化含有するリポソーム、並びにその調製方法、及びそれを含有する薬剤、整形剤
JP2922017B2 (ja) 経口用脂質膜構造体
JP2817883B2 (ja) 高度に完全なリポソームおよびその製剤法と用途
JP3272736B2 (ja) リポソーム製剤
JPH06183954A (ja) リポソーム製剤
JP3074732B2 (ja) 脂肪乳剤
JPH0482839A (ja) 蛋白質類・脂質小体複合体
JP2911550B2 (ja) リポソーム製剤